Actively Recruiting

Early Phase 1
Age: 0 - 45Years
FEMALE
NCT07403201

The Effect of Therapy Combination in PCOS With Dlbs 3233

Led by Inlacinpenelitian · Updated on 2026-02-11

90

Participants Needed

1

Research Sites

215 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital

CONDITIONS

Official Title

The Effect of Therapy Combination in PCOS With Dlbs 3233

Who Can Participate

Age: 0 - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Married and agree to join this research
Not Eligible

You will not qualify if you...

  • Disagree to join research

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

RS AMC Yogyakarta

Yogyakarta, DIY, Indonesia, 55253

Actively Recruiting

Loading map...

Research Team

P

prastika candra, s1

CONTACT

N

nazdifah fitriyani, s1

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here